Monday’s announcement of a $4.1m share purchase comes after the NZME director purchased $6.1m worth of shares in August.
The Medicare Administrative Contractor is setting up an expert panel to review coverage for tests, including for Cxbladder Triage.
New ANZ chief Nuno Matos continues to clear the decks and put the past behind him.
Two senior executives depart and several job titles adjust, with a chief operating officer to be appointed.
Locate Technologies says an NZX listing will remove restrictions and delays.
Listed telco infrastructure company's board in July recommended shareholders accept the 'low' offer from Tait Communications.
The listed insurer says the guidance is on condition no large natural disasters occur this month.
A higher price for Pacific Edge’s Cxbladder Triage Plus test has pushed up its share price and forecast profitability, Jarden analyst says.
Her long tenure on the board has been the subject of speculation in the investment community recently.
The goal of near-doubling revenue within five years follows a forecast dip in revenue for FY25.